BRPI0919412A8 - composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo. - Google Patents

composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo.

Info

Publication number
BRPI0919412A8
BRPI0919412A8 BRPI0919412A BRPI0919412A BRPI0919412A8 BR PI0919412 A8 BRPI0919412 A8 BR PI0919412A8 BR PI0919412 A BRPI0919412 A BR PI0919412A BR PI0919412 A BRPI0919412 A BR PI0919412A BR PI0919412 A8 BRPI0919412 A8 BR PI0919412A8
Authority
BR
Brazil
Prior art keywords
immunonutritional
immune response
nutritional composition
enhancing agent
response enhancing
Prior art date
Application number
BRPI0919412A
Other languages
English (en)
Inventor
Brassart Dominique
Schiffrin Eduardo
Burke Miller Kevin
Jacques Lantz Olivier
Diego Amigorena Sebastian
Original Assignee
Inst Curie
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Curie, Nestec Sa filed Critical Inst Curie
Publication of BRPI0919412A2 publication Critical patent/BRPI0919412A2/pt
Publication of BRPI0919412A8 publication Critical patent/BRPI0919412A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1783—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0919412A 2008-09-19 2009-09-11 composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo. BRPI0919412A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9825808P 2008-09-19 2008-09-19
US24107409P 2009-09-10 2009-09-10
PCT/US2009/056599 WO2010033426A2 (en) 2008-09-19 2009-09-11 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor

Publications (2)

Publication Number Publication Date
BRPI0919412A2 BRPI0919412A2 (pt) 2015-12-15
BRPI0919412A8 true BRPI0919412A8 (pt) 2018-03-13

Family

ID=41786110

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919412A BRPI0919412A8 (pt) 2008-09-19 2009-09-11 composição imunonutricional e nutricional,agente intensificador de resposta imunológica e uso do mesmo.

Country Status (12)

Country Link
US (1) US9827216B2 (pt)
EP (2) EP2344150A2 (pt)
JP (3) JP2012502998A (pt)
CN (1) CN102215837B (pt)
AU (1) AU2009293476B2 (pt)
BR (1) BRPI0919412A8 (pt)
CA (1) CA2736774C (pt)
MX (1) MX2011002984A (pt)
MY (1) MY155635A (pt)
RU (1) RU2011115182A (pt)
WO (1) WO2010033426A2 (pt)
ZA (1) ZA201102909B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150104425A1 (en) * 2006-07-24 2015-04-16 CortControl, Inc. Medical food for high cortisol breast cancer
JP2012502998A (ja) 2008-09-19 2012-02-02 ネステク ソシエテ アノニム 癌性腫瘍からの骨髄毒性を阻止又は軽減するための栄養支援
US20120270830A1 (en) * 2009-09-25 2012-10-25 Nestec S.A. Nutritional compositions including theanine and exogenous nucleotides
PH12013501773A1 (en) * 2011-03-31 2013-10-14 Nestec Sa Nutritional compositions for increasing arginine levels and methods of using same
WO2012141575A1 (en) * 2011-04-14 2012-10-18 N.V.Nutricia Combination of epa, dpa and/or dha with a chemotherapeutic agent
EP2876167A1 (en) 2013-11-21 2015-05-27 Institut Gustave Roussy Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment
US20150366941A1 (en) * 2014-06-19 2015-12-24 Cortcontrol Human disease treatment with medical food formulation
MX380541B (es) 2015-06-30 2025-03-12 Soc Des Produits Nestle S A Star Composición adecuada para proteger microorganismos.
CN108777999A (zh) * 2015-09-21 2018-11-09 小利兰·斯坦福大学理事会 癌症的营养治疗
CN105943564A (zh) * 2016-04-21 2016-09-21 徐忠琴 用于胰腺癌放化疗后减轻副作用的药物组合物
CN106722972A (zh) * 2017-03-21 2017-05-31 上海中优医学检验所有限公司 针对免疫调控能力相关基因个体化配方食品及其制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
EP3723772A4 (en) 2017-12-11 2021-09-08 Filtricine, Inc. COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR THE TREATMENT OF CANCER AND METABOLIC INTERVENTION THERAPY
CN111714616A (zh) * 2019-07-17 2020-09-29 江苏西宏生物医药有限公司 一种用于抗肿瘤的组合物
JP6838752B2 (ja) * 2019-08-30 2021-03-03 株式会社東洋新薬 血流改善組成物
CN110754656A (zh) * 2019-11-07 2020-02-07 上海奥医高科技实业有限公司 一种淋巴肿瘤功能专用型临床营养配方及其制备方法
CN111840523B (zh) * 2020-08-24 2021-08-31 中国农业科学院北京畜牧兽医研究所 一种含活性蛋白和活性脂肪酸的抗癌症的药物组合物
CN116761594A (zh) * 2020-12-22 2023-09-15 葛兰素史克消费保健（美国）控股有限责任公司 细胞健康营养产品
CN114344342B (zh) * 2021-12-29 2023-06-30 广东南芯医疗科技有限公司 副干酪乳杆菌Lp. R3在制备预防或治疗肿瘤药物中的应用
EP4658258A4 (en) * 2023-02-01 2026-07-08 St Jude Childrens Res Hospital Inc USE OF GLUTAMINE FOR CANCER TREATMENT AND TO IMPROVE THE EFFECTIVENESS OF IMMUNOTHERAPY

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576351A (en) 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
AUPN271295A0 (en) 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
US5330972A (en) 1993-05-28 1994-07-19 Abbott Laboratories Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
ES2243965T3 (es) 1996-07-09 2005-12-01 Societe Des Produits Nestle S.A. Procedimiento de secado mediante pulverizacion.
US6210700B1 (en) 1997-01-14 2001-04-03 Novartis Nutrition Ag Enhancement of transplant graft survival through nutritional immunomodulation with omega-9 fatty acid dietary supplement therapy
FR2802212B1 (fr) 1999-12-13 2002-03-01 Agronomique Inst Nat Rech Procede pour l'obtention d'une poudre contenant des micro-organismes viables, poudre obtenue selon ce procede et dispositif pour sa mise en oeuvre
ES2323450T3 (es) 2001-02-19 2009-07-16 Societe Des Produits Nestle S.A. Producto consumible que contiene probioticos.
US20030068385A1 (en) 2001-03-23 2003-04-10 Moyer Mary Pat Accelerated action fatty acid (AAFA) promotes health of normal tissues and minimizes the toxic side effects of chemotherapy
KR20050048539A (ko) 2001-10-06 2005-05-24 메리얼엘엘씨 ＣｐＧ 제제 및 관련된 방법
NZ538405A (en) 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
ES2677868T3 (es) 2003-10-16 2018-08-07 Nestec S.A. Composición nutricional frente a los efectos secundarios de la quimioterapia o de la radioterapia
AP2007003939A0 (en) * 2004-09-03 2007-04-30 Prometic Biosciences Inc Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
DE102005052367A1 (de) 2005-10-31 2007-05-03 Robert Bosch Gmbh Messgerät und Verfahren zur Ortung von in einem Medium eingeschlossenen Objekten mittels elektromagnetischer HF-Signale
CA2648126C (en) 2006-04-04 2012-12-18 Nestec S.A. Treatments using citrulline
JPWO2008047853A1 (ja) * 2006-10-19 2010-02-25 味の素株式会社 胃食道逆流症の予防・治療剤
JP2012502998A (ja) 2008-09-19 2012-02-02 ネステク ソシエテ アノニム 癌性腫瘍からの骨髄毒性を阻止又は軽減するための栄養支援

Also Published As

Publication number Publication date
EP2344150A2 (en) 2011-07-20
WO2010033426A2 (en) 2010-03-25
CA2736774A1 (en) 2010-03-25
BRPI0919412A2 (pt) 2015-12-15
JP6185500B2 (ja) 2017-08-23
CN102215837A (zh) 2011-10-12
JP2015038088A (ja) 2015-02-26
RU2011115182A (ru) 2012-10-27
AU2009293476B2 (en) 2013-01-24
CA2736774C (en) 2017-08-22
US20110223136A1 (en) 2011-09-15
EP2687209A1 (en) 2014-01-22
AU2009293476A1 (en) 2010-03-25
WO2010033426A3 (en) 2010-11-18
US9827216B2 (en) 2017-11-28
JP2012502998A (ja) 2012-02-02
MX2011002984A (es) 2011-08-08
MY155635A (en) 2015-11-13
JP2015131829A (ja) 2015-07-23
ZA201102909B (en) 2014-10-29
CN102215837B (zh) 2014-04-30

Similar Documents

Publication Publication Date Title
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
BRPI0923823A2 (pt) Agente de colaboração.
IL252561A0 (en) Antibodies against Siglac-15 polynucleotides encoding them, preparations containing them and their uses
IL211762A0 (en) Pegylated opiods, compositions comprising the same and uses thereof
IL209277A0 (en) Human anti-il-6/il-6r antibodies, compositions comprising the same and uses thereof
PL2315834T3 (pl) Białko rv2386c związane z gruźlicą, jego kompozycje i zastosowania
IL204607A0 (en) Antibodies against osteoclast - related protein siglec - 15, compositions comprising the same and uses thereof
IL212836A0 (en) Azaquinolinone derivatives, compositions comprising the same and uses thereof
PL1971366T3 (pl) Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposoby i zastosowanie
IL215603A0 (en) Human protein scaffold with controlled serum pharmacokinetics, compositions comprising the same and uses thereof
BRPI0821276A2 (pt) Produto, e, uso do produto
IL216014A0 (en) Antibodies immunorective with heregulin-her3 complexes, compositions comprising the same and uses thereof
BRPI0909084A2 (pt) Composição líquida, e, composto de peptídeo.
IL197831A (en) Human antibodies that bind 4cxcr, preparations containing them and their uses
IL220283A0 (en) 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
PL2354161T3 (pl) Przeciwciało anty -NR10 i jego zastosowanie
IL212278A0 (en) Morpholinopurine derivatives, compositions comprising the same and uses thereof
BRPI0806589A2 (pt) Catalisador, sua preparação e uso.
ZA201008348B (en) Alcohol alkoxylates, agents comprising the same and use of the alcohol alkoxylates as adjuvants in the agrochemical field.
BRPI0920953A2 (pt) dispositivo de manutenção, e uso do mesmo.
BRPI0815922A2 (pt) Artigo, composição, e, método.
BRPI0911252A2 (pt) método, extrato, e, composição.
IL207372A0 (en) Phenylpyrrole derivatives, compositions comprising the same and uses thereof
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
IT1397595B1 (it) Sostanze coloranti e loro utilizzazione in composizioni, in particolare in composizioni cosmetiche.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B25A Requested transfer of rights approved

Owner name: INSTITUT CURIE (FR) ; SOCIETE DES PRODUITS NESTLE

Owner name: INSTITUT CURIE (FR) ; SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]